Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 161 articles: HTML format Text format

Single Articles

October 2018
1. COOL J, Rosenblatt R, Kumar S, Lucero C, et al
   PORTAL VEIN THROMBOSIS PREVALENCE AND ASSOCIATED MORTALITY IN CIRRHOSIS IN A NATIONALLY REPRESENTATIVE INPATIENT COHORT.
   J Gastroenterol Hepatol. 2018 Oct 11. doi: 10.1111/jgh.14501.
   PubMed     Text format     Abstract available
   
   
   September 2018
2. HIROOKA M, Hiraoka A, Ochi H, Koizumi Y, et al
   No-touch radiofrequency ablation is an ideal method to prevent intrahepatic metastasis of hepatocellular carcinoma.
   J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14476.
   PubMed     Text format     Abstract available
   
   
   
3. MOLLER S, La Cour Sibbesen E, Madsen JL, Bendtsen F, et al
   The indocyanine green retention test in cirrhosis and portal hypertension. Accuracy and relation to severity of disease.
   J Gastroenterol Hepatol. 2018 Sep 17. doi: 10.1111/jgh.14470.
   PubMed     Text format     Abstract available
   
   
   
4. LU J, Xiong XZ, Cheng NS
   Hepatobiliary and Pancreatic: Inflammatory myofibroblastic tumor of the liver mimicking intrahepatic cholangiocarcinoma with hilar lymph node metastasis.
   J Gastroenterol Hepatol. 2018 Sep 14. doi: 10.1111/jgh.14444.
   PubMed     Text format    
   
   
   
5. XU X, Cong L, Zhao Y
   Hepatobiliary and Pancreatic: Tumor to tumor metastasis from a primary insulinoma to a hepatic adenoma.
   J Gastroenterol Hepatol. 2018 Sep 6. doi: 10.1111/jgh.14443.
   PubMed     Text format    
   
   
   August 2018
6. KAKISAKA K, Suzuki Y, Fujiwara Y, Suzuki A, et al
   Lysophosphatidylcholine acyltransferase 3 is decreased in non-alcoholic steatohepatitis, resulting in caspase-independent hepatocyte death.
   J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14461.
   PubMed     Text format     Abstract available
   
   
   
7. KOZUKA R, Enomoto M, Sato-Matsubara M, Yoshida K, et al
   HLA-DQA1/DRB1 Polymorphism is Associated with the Development of Hepatocellular Carcinoma during Entecavir Treatment.
   J Gastroenterol Hepatol. 2018 Aug 30. doi: 10.1111/jgh.14454.
   PubMed     Text format     Abstract available
   
   
   
8. KHAN F, Parikh MP, McCullough AJ
   Hepatobiliary and Pancreatic: Mauriac syndrome: A rare cause of elevated liver enzymes.
   J Gastroenterol Hepatol. 2018 Aug 16. doi: 10.1111/jgh.14381.
   PubMed     Text format    
   
   
   
9. WU SC, Chen WT, Muo CH, Hsu CY, et al
   A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
   J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
   PubMed     Text format     Abstract available
   
   
   
10. YAMADA N, Katano T, Hirata Y, Okada N, et al
    Serum Mac-2 Binding Protein Glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14438.
    PubMed     Text format     Abstract available
    
    
    
11. KENSTON SSF, Song X, Li Z, Zhao J, et al
    Mechanistic insight, diagnosis and treatment of ammonia induced hepatic encephalopathy.
    J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14408.
    PubMed     Text format     Abstract available
    
    
    
12. EUN HS, Cho SY, Lee BS, Kim S, et al
    Cytochrome P450 4A11 expression in tumor cells is a favorable prognostic factor for hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2018 Aug 2. doi: 10.1111/jgh.14406.
    PubMed     Text format     Abstract available
    
    
    
13. TARANTINO G, Porcu C, Arciello M, Andreozzi P, et al
    Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability.
    J Gastroenterol Hepatol. 2018;33:1511-1517.
    PubMed     Text format     Abstract available
    
    
    
14. WANG J, Ma L, Chen S, Xu L, et al
    Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    J Gastroenterol Hepatol. 2018;33:1518-1523.
    PubMed     Text format     Abstract available
    
    
    July 2018
15. KIM TH, Lee HA, Seo YS, Lee YR, et al
    Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-beta-D-glucosaminidase.
    J Gastroenterol Hepatol. 2018 Jul 30. doi: 10.1111/jgh.14387.
    PubMed     Text format     Abstract available
    
    
    
16. HIRAOKA A, Kumada T, Ogawa C, Kariyama K, et al
    Proposed After Direct Acting Antivirals Recommendation for Surveillance (ADRES) score for scheduled ultrasonography surveillance for hepatocellular carcinoma: multicenter analysis.
    J Gastroenterol Hepatol. 2018 Jul 11. doi: 10.1111/jgh.14378.
    PubMed     Text format     Abstract available
    
    
    
17. YEAP SP, Harley H, Thompson R, Williamson KD, et al
    Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications.
    J Gastroenterol Hepatol. 2018 Jul 10. doi: 10.1111/jgh.14376.
    PubMed     Text format     Abstract available
    
    
    
18. WANG HW, Lai HC, Hu TH, Su WP, et al
    Modified FIB-4 index stratifies hepatocellular carcinoma risk in chronic hepatitis B patients on entecavir therapy.
    J Gastroenterol Hepatol. 2018 Jul 3. doi: 10.1111/jgh.14372.
    PubMed     Text format     Abstract available
    
    
    June 2018
19. HUANG CF, Wang SC, Yeh ML, Huang CI, et al
    Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
    J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14359.
    PubMed     Text format     Abstract available
    
    
    
20. LEE DH, Ahn JH, Chung JW, Kim YJ, et al
    Varices on CT is Surrogate of Clinically Significant Portal Hypertension and can Predict Survival in Compensated Cirrhosis Patients.
    J Gastroenterol Hepatol. 2018 Jun 14. doi: 10.1111/jgh.14319.
    PubMed     Text format     Abstract available
    
    
    
21. KAWAKAMI Y, Suzuki K, Miyake T, Hayashi Y, et al
    Hepatobiliary and Pancreatic: Hepatic alveolar echinococcosis mimics cholangiocarcinoma: Role of EUS-FNA.
    J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14279.
    PubMed     Text format    
    
    
    
22. WANG YF, Chen HQ
    Hepatobiliary and Pancreatic: Spontaneous cholecystocutaneous fistula.
    J Gastroenterol Hepatol. 2018 Jun 12. doi: 10.1111/jgh.14285.
    PubMed     Text format    
    
    
    
23. LUO Q, Pang Z, Liu C, Liu X, et al
    Hepatobiliary and Pancreatic: Spontaneous hepatic hemorrhage caused by Ehlers-Danlos syndrome.
    J Gastroenterol Hepatol. 2018 Jun 11. doi: 10.1111/jgh.14278.
    PubMed     Text format    
    
    
    
24. HONG J, Wang K, Yu Y
    Hepatobiliary and Pancreatic: Malignant pancreatic perivascular epithelioid cell tumor mimicking pancreatic neuroendocrine tumor.
    J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14272.
    PubMed     Text format    
    
    
    
25. YAMASHIMA M, Ozawa E, Ohnita K, Tabata K, et al
    Hepatobiliary and Pancreatic: Pancreatic mixed serous neuroendocrine neoplasm in von Hippel-Lindau disease.
    J Gastroenterol Hepatol. 2018 Jun 10. doi: 10.1111/jgh.14274.
    PubMed     Text format    
    
    
    
26. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
    Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
    PubMed     Text format     Abstract available
    
    
    
27. LIU T, Xu L, Wang C, Chen K, et al
    Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
    PubMed     Text format     Abstract available
    
    
    
28. DONG XQ, Li J, Liu H, Wang YW, et al
    Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
    PubMed     Text format    
    
    
    
29. LIN YX, Fu YY, Cui T, Jia QB, et al
    Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
    J Gastroenterol Hepatol. 2018;33:1167.
    PubMed     Text format    
    
    
    
30. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
    Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
    J Gastroenterol Hepatol. 2018;33:1166.
    PubMed     Text format    
    
    
    
31. MAHADY SE, Adams LA
    Burden of non-alcoholic fatty liver disease in Australia.
    J Gastroenterol Hepatol. 2018;33 Suppl 1:1-11.
    PubMed     Text format     Abstract available
    
    
    
32. KOO BK, Joo SK, Kim D, Bae JM, et al
    Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2018;33:1277-1285.
    PubMed     Text format     Abstract available
    
    
    May 2018
33. AZUMA S, Kurita A, Yazumi S
    Hepatobiliary and Pancreatic: Burkitt lymphoma mimicking IgG4-related disease.
    J Gastroenterol Hepatol. 2018 May 28. doi: 10.1111/jgh.14276.
    PubMed     Text format    
    
    
    
34. KANG MK, Goo EJ, Kim SB, Kim KH, et al
    Hepatobiliary and Pancreatic: Intrahepatic cholangiocarcinoma with distant cutaneous metastases to the face.
    J Gastroenterol Hepatol. 2018 May 16. doi: 10.1111/jgh.14091.
    PubMed     Text format    
    
    
    
35. KATO S, Kuwatani M, Kawakubo K, Sugiura R, et al
    Hepatobiliary and Pancreatic: Pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis.
    J Gastroenterol Hepatol. 2018 May 15. doi: 10.1111/jgh.14088.
    PubMed     Text format    
    
    
    
36. YASUDA S, Ishigami M, Ishizu Y, Kuzuya T, et al
    Substitutions in interferon sensitivity determining region and hepatocarcinogenesis after hepatitis C virus eradication.
    J Gastroenterol Hepatol. 2018 May 9. doi: 10.1111/jgh.14280.
    PubMed     Text format     Abstract available
    
    
    
37. UOJIMA H, Hidaka H, Tanaka Y, Inoue T, et al
    Wisteria floribunda agglutinin-positive human Mac-2 binding protein in decompensated cirrhosis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14277.
    PubMed     Text format     Abstract available
    
    
    
38. MANATSATHIT W, Samant H, Kapur S, Ingviya T, et al
    Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score, in detection of esophageal varices: systemic review and meta-analysis.
    J Gastroenterol Hepatol. 2018 May 8. doi: 10.1111/jgh.14271.
    PubMed     Text format     Abstract available
    
    
    
39. KOBAYASHI M, Ryozawa S, Nagata K
    Hepatobiliary and Pancreatic: A case of pure squamous cell carcinoma of the gallbladder.
    J Gastroenterol Hepatol. 2018;33:976.
    PubMed     Text format    
    
    
    
40. LAINO ME, Ragucci M, Klimstra DS, Mannelli L, et al
    Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy.
    J Gastroenterol Hepatol. 2018;33:977.
    PubMed     Text format    
    
    
    
41. KAMIJO Y
    Is hepatic peroxisome proliferator-activated receptor alpha essential for the metabolic effects of fibrates?
    J Gastroenterol Hepatol. 2018;33:978-979.
    PubMed     Text format    
    
    
    
42. WONG GL
    Non-invasive assessments for liver fibrosis: The crystal ball we long for.
    J Gastroenterol Hepatol. 2018;33:1009-1015.
    PubMed     Text format     Abstract available
    
    
    
43. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    PubMed     Text format     Abstract available
    
    
    
44. TAMAI T, Taniyama O, Oda K, Kasai A, et al
    Reduction effect of the quantity of radiation exposure and contrast media by image support system in transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018;33:1115-1122.
    PubMed     Text format     Abstract available
    
    
    
45. GUARINO M, Tortora R, de Stefano G, Coppola C, et al
    Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
    J Gastroenterol Hepatol. 2018;33:1123-1130.
    PubMed     Text format     Abstract available
    
    
    April 2018
46. HAMOIR C, de Vos M, Clinckart F, Nicaise G, et al
    Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy.
    J Gastroenterol Hepatol. 2018 Apr 29. doi: 10.1111/jgh.14136.
    PubMed     Text format    
    
    
    
47. HABIB S, Patel N, Yarlagadda S, Hsu CH, et al
    Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14267.
    PubMed     Text format     Abstract available
    
    
    
48. SHIRAISHI Y, Imai K, Yamashita YI, Nakao Y, et al
    Hepatobiliary and Pancreatic: Segmental arterial mediolysis of pancreaticoduodenal artery accompanied by acute pancreatitis and duodenal obstruction.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14138.
    PubMed     Text format    
    
    
    
49. ZHANG L, Gao H, Feng Y, Wang G, et al
    Hepatobiliary and Pancreatic: Obliterative portal venopathy found in Castleman disease variant of POEMS syndrome.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14084.
    PubMed     Text format    
    
    
    
50. CATERSON H, Liu K
    Hepatobiliary and Pancreatic: Rare hepatic vascular tumor presenting with hypertrophic osteoarthropathy.
    J Gastroenterol Hepatol. 2018 Apr 24. doi: 10.1111/jgh.14087.
    PubMed     Text format    
    
    
    
51. SESHACHALAM VP, Sekar K, Hui KM
    Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    J Gastroenterol Hepatol. 2018 Apr 19. doi: 10.1111/jgh.14262.
    PubMed     Text format     Abstract available
    
    
    
52. NIMRI L, Staikin K, Peri I, Yehuda-Shnaidman E, et al
    Ostreolysin induces browning of adipocytes and ameliorates hepatic steatosis.
    J Gastroenterol Hepatol. 2018 Apr 16. doi: 10.1111/jgh.14259.
    PubMed     Text format     Abstract available
    
    
    
53. KODAMA K, Kawaoka T, Aikata H, Uchikawa S, et al
    Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    J Gastroenterol Hepatol. 2018 Apr 12. doi: 10.1111/jgh.14152.
    PubMed     Text format     Abstract available
    
    
    
54. LIN YX, Hu HJ, Li FY, Jia QB, et al
    Hepatobiliary and Pancreatic: Biliary reoperation for recurrent intrahepatic stones in patients with polysplenia syndrome.
    J Gastroenterol Hepatol. 2018 Apr 6. doi: 10.1111/jgh.14137.
    PubMed     Text format    
    
    
    
55. YANG MJ, Kim JH, Kim DJ, Hwang JC, et al
    Hepatobiliary and Pancreatic: EUS-guided reintervention for extraluminal stent migration after EUS-guided hepaticogastrostomy.
    J Gastroenterol Hepatol. 2018;33:772.
    PubMed     Text format    
    
    
    
56. KANG MK, Kim TN
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma diagnosed by proptosis due to metastatic orbital mass.
    J Gastroenterol Hepatol. 2018;33:773.
    PubMed     Text format    
    
    
    
57. MIYATA T, Tajima H, Hirata M, Nakanuma SI, et al
    Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
    J Gastroenterol Hepatol. 2018;33:950-957.
    PubMed     Text format     Abstract available
    
    
    
58. SONG DS, Kim TY, Kim DJ, Kim HY, et al
    Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure.
    J Gastroenterol Hepatol. 2018;33:900-909.
    PubMed     Text format     Abstract available
    
    
    March 2018
59. CHAN WK, Mustapha NRN, Mahadeva S, Wong VW, et al
    Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14150.
    PubMed     Text format     Abstract available
    
    
    
60. TANDON P, Bishay K, Fisher S, Yelle D, et al
    Comparison of Clinical Outcomes Between Variceal and Non-Variceal Gastrointestinal Bleeding in Patients with Cirrhosis.
    J Gastroenterol Hepatol. 2018 Mar 30. doi: 10.1111/jgh.14147.
    PubMed     Text format     Abstract available
    
    
    
61. PARK SW, Jun CH, Choi SK, Kim HJ, et al
    Hepatobiliary and Pancreatic: A black liver of Dubin-Johnson syndrome.
    J Gastroenterol Hepatol. 2018;33:562.
    PubMed     Text format    
    
    
    
62. VANBRUGGHE C, Tabchouri N, Louis G, Del Grande J, et al
    Hepatobiliary and Pancreatic: A rare form of autoimmune pancreatitis mimicking mixed-type intraductal papillary mucinous neoplasm.
    J Gastroenterol Hepatol. 2018;33:563.
    PubMed     Text format    
    
    
    
63. PAPALUCA T, Gow P
    Terlipressin: Current and emerging indications in chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:591-598.
    PubMed     Text format     Abstract available
    
    
    
64. ABE K, Takahashi A, Imaizumi H, Hayashi M, et al
    Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease.
    J Gastroenterol Hepatol. 2018;33:733-740.
    PubMed     Text format     Abstract available
    
    
    February 2018
65. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    PubMed     Text format     Abstract available
    
    
    
66. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    PubMed     Text format     Abstract available
    
    
    
67. YAMADA T, Nakanishi Y, Okamura K, Tsuchikawa T, et al
    Impact of serum CA19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14124.
    PubMed     Text format     Abstract available
    
    
    
68. DOI H, Hayashi E, Arai J, Tojo M, et al
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia.
    J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123.
    PubMed     Text format     Abstract available
    
    
    
69. HACZEYNI F, Yeh MM, Ioannou GN, Leclercq IA, et al
    Mouse Models Of Nonalcoholic Steatohepatitis: A Reflection On Recent Literature.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14122.
    PubMed     Text format     Abstract available
    
    
    
70. OKUNO N, Hara K, Mizuno N, Kuwahara T, et al
    Efficacy of the 6-mm FCSEMS during EUS-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult ERCP: a prospective clinical study.
    J Gastroenterol Hepatol. 2018 Feb 9. doi: 10.1111/jgh.14112.
    PubMed     Text format     Abstract available
    
    
    
71. WANG Q, Wang G, Wang Y, Liu C, et al
    ALKBH3 expression is associated with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117.
    PubMed     Text format     Abstract available
    
    
    
72. ZHANG LH, Tai Y, Tong H, Lei XJ, et al
    Hepatobiliary and Pancreatic: Rare cause of obstructive jaundice by Trichosporon asahii.
    J Gastroenterol Hepatol. 2018;33:338.
    PubMed     Text format    
    
    
    
73. JAISWAL P, Jaiswal R, Attar BM, Dedania B, et al
    Hepatobiliary and Pancreatic: Massive hepatic cystic echinococcosis compressing inferior vena cava.
    J Gastroenterol Hepatol. 2018;33:339.
    PubMed     Text format    
    
    
    
74. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
    Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2018;33:511-517.
    PubMed     Text format     Abstract available
    
    
    
75. DUAN X, Meng Q, Wang C, Liu Z, et al
    Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    J Gastroenterol Hepatol. 2018;33:533-542.
    PubMed     Text format     Abstract available
    
    
    January 2018
76. MANCEBO A, Varela M, Gonzalez-Dieguez ML, Navascues CA, et al
    Incidence and Risk Factors Associated with Hepatocellular Carcinoma Surveillance Failure.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14108.
    PubMed     Text format     Abstract available
    
    
    
77. ZHANG F, Zhang J, Li X, Li B, et al
    The Notch signaling pathway regulates cell cycle in proliferating hepatocytes involved in liver regeneration.
    J Gastroenterol Hepatol. 2018 Jan 31. doi: 10.1111/jgh.14110.
    PubMed     Text format     Abstract available
    
    
    
78. KAO JH, Yu ML, Chen CY, Peng CY, et al
    Twelve-week Ravidasvir plus ritonavir-boosted Danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
    J Gastroenterol Hepatol. 2018 Jan 18. doi: 10.1111/jgh.14096.
    PubMed     Text format     Abstract available
    
    
    
79. KIM NH, Lee T, Cho YK, Kim BI, et al
    Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization.
    J Gastroenterol Hepatol. 2018 Jan 3. doi: 10.1111/jgh.14083.
    PubMed     Text format     Abstract available
    
    
    
80. FANG X, Liu LW, Dong J, Zhang J, et al
    A study about immunomodulatory effect and efficacy and prognosis of hUCMSCs in patients with CHB-induced decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jan 2. doi: 10.1111/jgh.14081.
    PubMed     Text format     Abstract available
    
    
    
81. HARIMOTO N, Yugawa K, Ikegami T, Ohira M, et al
    Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.
    J Gastroenterol Hepatol. 2018;33:9.
    PubMed     Text format    
    
    
    
82. CRIMI F, Guido M, Pomerri F
    Hepatobiliary and Pancreatic: Hepatic nodules in a patient with familial adenomatous polyposis and colorectal adenocarcinoma.
    J Gastroenterol Hepatol. 2018;33:8.
    PubMed     Text format    
    
    
    
83. NAKAJIMA S, Tanaka H, Sawada K, Hayashi H, et al
    Polymorphism of receptor-type tyrosine-protein phosphatase delta gene in the development of non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2018;33:283-290.
    PubMed     Text format     Abstract available
    
    
    
84. KAKISAKA K, Suzuki Y, Kataoka K, Okada Y, et al
    Predictive formula of coma onset and prothrombin time to distinguish patients who recover from acute liver injury.
    J Gastroenterol Hepatol. 2018;33:277-282.
    PubMed     Text format     Abstract available
    
    
    
85. EDA K, Mizuochi T, Iwama I, Inui A, et al
    Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan.
    J Gastroenterol Hepatol. 2018;33:264-269.
    PubMed     Text format     Abstract available
    
    
    December 2017
86. KAWASHITA Y, Morine Y, Saito Y, Takasu C, et al
    Role of HSF1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
    J Gastroenterol Hepatol. 2017 Dec 26. doi: 10.1111/jgh.14078.
    PubMed     Text format     Abstract available
    
    
    
87. ATSUKAWA M, Tsubota A, Kato K, Abe H, et al
    Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14047.
    PubMed     Text format     Abstract available
    
    
    
88. ZHOU LY, Ma YJ, Tian F
    Hepatobiliary and Pancreatic: Management of bleeding colonic varices in liver disease.
    J Gastroenterol Hepatol. 2017;32:1913.
    PubMed     Text format    
    
    
    
89. CHOUDHURY A, Kumar M, Sharma BC, Maiwall R, et al
    Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.
    J Gastroenterol Hepatol. 2017;32:1989-1997.
    PubMed     Text format     Abstract available
    
    
    November 2017
90. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
    Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
    PubMed     Text format     Abstract available
    
    
    
91. LI G, Brocker CN, Xie C, Yan T, et al
    Hepatic PPARalpha mediates the major metabolic effects of Wy-14643.
    J Gastroenterol Hepatol. 2017 Nov 15. doi: 10.1111/jgh.14046.
    PubMed     Text format     Abstract available
    
    
    
92. SCHLEVOGT B, Rehkamper J, Hild B, Schmidt HH, et al
    Hepatobiliary and Pancreatic: Fulminant liver failure from diffuse leukemoid hepatic infiltration of melanoma.
    J Gastroenterol Hepatol. 2017;32:1795.
    PubMed     Text format    
    
    
    
93. LLOP E, Lopez M, de la Revilla J, Fernandez N, et al
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.
    J Gastroenterol Hepatol. 2017;32:1867-1872.
    PubMed     Text format     Abstract available
    
    
    
94. HIROOKA M, Koizumi Y, Imai Y, Nakamura Y, et al
    Clinical utility of multipolar ablation with a 3-D simulator system for patients with liver cancer.
    J Gastroenterol Hepatol. 2017;32:1852-1858.
    PubMed     Text format     Abstract available
    
    
    October 2017
95. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
    Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
    J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
    PubMed     Text format     Abstract available
    
    
    
96. OTANI I, Oka S, Tanaka S, Tsuboi A, et al
    Clinical significance of small-bowel villous edema in patients with liver cirrhosis-a capsule endoscopy study.
    J Gastroenterol Hepatol. 2017 Oct 10. doi: 10.1111/jgh.14016.
    PubMed     Text format     Abstract available
    
    
    
97. CHOE EY, Lee YH, Choi YJ, Huh BW, et al
    Waist-to-calf ratio is an independent predictor of hepatic steatosis and fibrosis patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2017 Oct 8. doi: 10.1111/jgh.14011.
    PubMed     Text format     Abstract available
    
    
    
98. SHI SH, Feng XN, Wang ZY, Sun K, et al
    Pyogenic liver abscess related to intrahepatic bile duct stones: difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
    J Gastroenterol Hepatol. 2017 Oct 6. doi: 10.1111/jgh.14010.
    PubMed     Text format     Abstract available
    
    
    
99. DING F, Li Q, Duan X, Ye J, et al
    Hepatobiliary and Pancreatic: Ruptured aneurysm of intra-hepatic portal vein causing obstructive jaundice.
    J Gastroenterol Hepatol. 2017;32:1666.
    PubMed     Text format    
    
    
    
100. GILES H, Ross A, Gearry RB
     Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.
     J Gastroenterol Hepatol. 2017;32:1663.
     PubMed     Text format    
     
     
     
101. NGUYEN BD
     Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
     J Gastroenterol Hepatol. 2017;32:1667.
     PubMed     Text format    
     
     
     
102. ZHENG YX, Zhong X, Li YJ, Fan XG, et al
     Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis.
     J Gastroenterol Hepatol. 2017;32:1668-1678.
     PubMed     Text format     Abstract available
     
     
     
103. PUIGVEHI M, Broquetas T, Coll S, Garcia-Retortillo M, et al
     Impact of anthropometric features on the applicability and accuracy of FibroScan((R)) (M and XL) in overweight/obese patients.
     J Gastroenterol Hepatol. 2017;32:1746-1753.
     PubMed     Text format     Abstract available
     
     
     
104. LIN YJ, Gao XM, Pan WW, Gao S, et al
     A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
     J Gastroenterol Hepatol. 2017;32:1739-1745.
     PubMed     Text format     Abstract available
     
     
     September 2017
105. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
     Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.
     J Gastroenterol Hepatol. 2017 Sep 15. doi: 10.1111/jgh.13989.
     PubMed     Text format     Abstract available
     
     
     
106. SEO YS, Park SY, Kim MY, Kim SG, et al
     Serum cystatin C level is an excellent predictor of mortality in patients with cirrhotic ascites.
     J Gastroenterol Hepatol. 2017 Sep 14. doi: 10.1111/jgh.13983.
     PubMed     Text format     Abstract available
     
     
     
107. ZHANG B, Zhang CG, Ji LH, Zhao G, et al
     Estrogen receptor beta selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells.
     J Gastroenterol Hepatol. 2017 Sep 7. doi: 10.1111/jgh.13976.
     PubMed     Text format     Abstract available
     
     
     
108. ESO Y, Takai A, Arasawa S, Ueda Y, et al
     Hepatobiliary and Pancreatic: Granulomatous hepatitis due to disseminated bacillus Calmette-Guerin disease.
     J Gastroenterol Hepatol. 2017;32:1538.
     PubMed     Text format    
     
     
     
109. LIU PC, Wu MS, Hsieh MC, Suk FM, et al
     Hepatobiliary and Pancreatic: Development from gallbladder stone to gallstone ileus.
     J Gastroenterol Hepatol. 2017;32:1539.
     PubMed     Text format    
     
     
     
110. LV XH, Wang CH, Xie Y
     Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
     J Gastroenterol Hepatol. 2017;32:1540-1547.
     PubMed     Text format     Abstract available
     
     
     
111. JIA Z, Paz-Fumagalli R, Frey G, Sella DM, et al
     Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
     J Gastroenterol Hepatol. 2017;32:1617-1623.
     PubMed     Text format     Abstract available
     
     
     
112. CRESCI GA, Glueck B, McMullen MR, Xin W, et al
     Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.
     J Gastroenterol Hepatol. 2017;32:1587-1597.
     PubMed     Text format     Abstract available
     
     
     August 2017
113. GERAGE AM, Ritti-Dias RM, Balagopal B, de Oliveira Conceicao RD, et al
     Physical activity levels and hepatic steatosis: a longitudinal follow up study in adults.
     J Gastroenterol Hepatol. 2017 Aug 30. doi: 10.1111/jgh.13965.
     PubMed     Text format     Abstract available
     
     
     
114. LEE EC, Park SJ, Han SS, Shim JR, et al
     Risk Prediction of Post-Hepatectomy Liver Failure in Patients with Perihilar Cholangiocarcinoma.
     J Gastroenterol Hepatol. 2017 Aug 26. doi: 10.1111/jgh.13966.
     PubMed     Text format     Abstract available
     
     
     
115. CHIRAPONGSATHORN S, Bunraksa W, Chaiprasert A, Punpanich D, et al
     Adding C-reactive protein and procalcitonin to the MELD score improves mortality prediction in patients with complications of cirrhosis.
     J Gastroenterol Hepatol. 2017 Aug 25. doi: 10.1111/jgh.13928.
     PubMed     Text format     Abstract available
     
     
     
116. AMPUERO J, Montoliu C, Simon-Talero M, Aguilera V, et al
     Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.
     J Gastroenterol Hepatol. 2017 Aug 2. doi: 10.1111/jgh.13917.
     PubMed     Text format     Abstract available
     
     
     
117. HO CM, Wu CH, Liau JY
     Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
     J Gastroenterol Hepatol. 2017;32:1424.
     PubMed     Text format    
     
     
     
118. MATSUMURA K, Hashimoto D, Umezaki N, Nakagawa S, et al
     Hepatobiliary and Pancreatic: Portal vein stent for local recurrence of bile duct cancer.
     J Gastroenterol Hepatol. 2017;32:1425.
     PubMed     Text format    
     
     
     July 2017
119. DE SANTIS A, Nardelli S, Bassanelli C, Lupo M, et al
     The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.
     J Gastroenterol Hepatol. 2017 Jul 28. doi: 10.1111/jgh.13907.
     PubMed     Text format     Abstract available
     
     
     
120. ELNEGOULY M, Umgelter K, Safi W, Hapfelmeier A, et al
     Elevated Cardiac Troponin T in Cirrhotic Patients with Emergency Care Admissions is Associated with Mortality.
     J Gastroenterol Hepatol. 2017 Jul 20. doi: 10.1111/jgh.13902.
     PubMed     Text format     Abstract available
     
     
     
121. KIMER N, Pedersen JS, Tavenier J, Christensen JE, et al
     Rifaximin has minor effects on bacterial composition, inflammation and bacterial translocation in cirrhosis; A randomized trial.
     J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13852.
     PubMed     Text format     Abstract available
     
     
     
122. ZHONG X, Liu H
     Honokiol attenuates Diet-Induced Nonalcoholic Steatohepatitis by regulating macrophage polarization through activating PPARgamma.
     J Gastroenterol Hepatol. 2017 Jul 2. doi: 10.1111/jgh.13853.
     PubMed     Text format     Abstract available
     
     
     
123. COSTA JM, Costa D, Vieira F, Rolanda C, et al
     Hepatobiliary and Pancreatic: Giant hepatomegaly from hepatic hemagiomatosis.
     J Gastroenterol Hepatol. 2017;32:1285.
     PubMed     Text format    
     
     
     
124. AGARWAL J, Hasan A, Mehrotra M
     Hepatobiliary and Pancreatic: Hepatogastric fistula.
     J Gastroenterol Hepatol. 2017;32:1284.
     PubMed     Text format    
     
     
     
125. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
     Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
     J Gastroenterol Hepatol. 2017;32:1378-1386.
     PubMed     Text format     Abstract available
     
     
     
126. LOONG TC, Wei JL, Leung JC, Wong GL, et al
     Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
     J Gastroenterol Hepatol. 2017;32:1363-1369.
     PubMed     Text format     Abstract available
     
     
     June 2017
127. KIM BS, Seo YS, Kim YS, Lee CH, et al
     Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
     J Gastroenterol Hepatol. 2017 Jun 30. doi: 10.1111/jgh.13854.
     PubMed     Text format     Abstract available
     
     
     
128. FUJITA K, Niki T, Nomura T, Oura K, et al
     Serum galectin-9 levels are correlated to liver fibrosis regardless of chronic inflammation or hepatocellular carcinoma complications.
     J Gastroenterol Hepatol. 2017 Jun 15. doi: 10.1111/jgh.13851.
     PubMed     Text format     Abstract available
     
     
     
129. SZKLARUK J, Kaya D, Wei W
     Evaluation of the Added Value of Imaging the Pelvis in Patients with Hepatocellular Cancer.
     J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13847.
     PubMed     Text format     Abstract available
     
     
     
130. KIM BH, Lim YS, Kim EY, Kong HJ, et al
     Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population.
     J Gastroenterol Hepatol. 2017 Jun 14. doi: 10.1111/jgh.13848.
     PubMed     Text format     Abstract available
     
     
     
131. ZHANG X, Li J, Shen F, Lau WY, et al
     Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
     J Gastroenterol Hepatol. 2017 Jun 6. doi: 10.1111/jgh.13843.
     PubMed     Text format     Abstract available
     
     
     
132. LING QA, Yo J, Gerstenmaier JF, Kemp W, et al
     Hepatobiliary and Pancreatic: Hepatic and mesenteric aneurysms with biloma formation.
     J Gastroenterol Hepatol. 2017;32:1134.
     PubMed     Text format    
     
     
     
133. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
     Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
     J Gastroenterol Hepatol. 2017;32:1240-1249.
     PubMed     Text format     Abstract available
     
     
     May 2017
134. LIU CH, Liu CJ, Hong CM, Su TH, et al
     A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
     J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
     PubMed     Text format     Abstract available
     
     
     
135. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
     Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
     J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
     PubMed     Text format     Abstract available
     
     
     
136. KIM JH, Lim KS, Min YW, Lee H, et al
     Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
     J Gastroenterol Hepatol. 2017;32:1064-1070.
     PubMed     Text format     Abstract available
     
     
     
137. MAIA L, Ferreira JM, Pedroto I
     Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
     J Gastroenterol Hepatol. 2017;32:948.
     PubMed     Text format    
     
     
     
138. JUN DW, Kim SG, Park SH, Jin SY, et al
     External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.
     J Gastroenterol Hepatol. 2017;32:1094-1099.
     PubMed     Text format     Abstract available
     
     
     
139. PARKER R, Hodson J, Rowe IAC
     Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis.
     J Gastroenterol Hepatol. 2017;32:950-956.
     PubMed     Text format     Abstract available
     
     
     
140. RASHID HO, Kim HK, Junjappa R, Kim HR, et al
     Endoplasmic reticulum stress in the regulation of liver diseases: Involvement of Regulated IRE1alpha and beta-dependent decay and miRNA.
     J Gastroenterol Hepatol. 2017;32:981-991.
     PubMed     Text format     Abstract available
     
     
     April 2017
141. ITO K, Murotani K, Nakade Y, Inoue T, et al
     Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
     J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
     PubMed     Text format     Abstract available
     
     
     
142. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
     Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
     J Gastroenterol Hepatol. 2017;32:738.
     PubMed     Text format    
     
     
     
143. LOURENCO LC, Horta DV, Reis J
     Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
     J Gastroenterol Hepatol. 2017;32:739.
     PubMed     Text format    
     
     
     
144. LIU PH, Hsu CY, Hsia CY, Lee YH, et al
     ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
     J Gastroenterol Hepatol. 2017;32:879-886.
     PubMed     Text format     Abstract available
     
     
     
145. NJEI B, McCarty TR, Laine L
     Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
     J Gastroenterol Hepatol. 2017;32:852-858.
     PubMed     Text format     Abstract available
     
     
     March 2017
146. JIANG T, Du F, Qin N, Lu Q, et al
     Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
     J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
     PubMed     Text format     Abstract available
     
     
     
147. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
     Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
     J Gastroenterol Hepatol. 2017;32:547.
     PubMed     Text format    
     
     
     
148. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
     Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
     J Gastroenterol Hepatol. 2017;32:546.
     PubMed     Text format    
     
     
     
149. ZENG XQ, Ma LL, Tseng YJ, Chen J, et al
     Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices: A randomized pilot study.
     J Gastroenterol Hepatol. 2017;32:631-638.
     PubMed     Text format     Abstract available
     
     
     February 2017
150. CHONG CC, Wong GL, Chan AW, Wong VW, et al
     Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study.
     J Gastroenterol Hepatol. 2017;32:506-514.
     PubMed     Text format     Abstract available
     
     
     
151. SHI KQ, Cai YJ, Lin Z, Dong JZ, et al
     Development and validation of a prognostic nomogram for acute-on-chronic hepatitis B liver failure.
     J Gastroenterol Hepatol. 2017;32:497-505.
     PubMed     Text format     Abstract available
     
     
     January 2017
152. POLLOCK G, Minuk GY
     Diagnostic Considerations for Cholestatic Liver Disease.
     J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
     PubMed     Text format     Abstract available
     
     
     
153. RATHOD K, Deshmukh H, Shukla A, Popat B, et al
     Endovascular treatment of Budd-Chiari syndrome: Single center experience.
     J Gastroenterol Hepatol. 2017;32:237-243.
     PubMed     Text format     Abstract available
     
     
     
154. CHOI HJ, Moon JH, Kim HK, Lee YN, et al
     KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses.
     J Gastroenterol Hepatol. 2017;32:154-162.
     PubMed     Text format     Abstract available
     
     
     October 2016
155. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
     Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
     J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
     PubMed     Text format     Abstract available
     
     
     July 2016
156. PARK TY, Lee SK, Nam K, Oh D, et al
     Spontaneous hemobilia after liver transplantation: frequency, risk factors, and outcome of endoscopic management.
     J Gastroenterol Hepatol. 2016 Jul 23. doi: 10.1111/jgh.13497.
     PubMed     Text format     Abstract available
     
     
     May 2016
157. OGURA T, Onda S, Takagi W, Sano T, et al
     Clinical utility of Endoscopic ultrasound-guided biliary drainage as a rescue of re-intervention procedure for high-grade hilar stricture.
     J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13437.
     PubMed     Text format     Abstract available
     
     
     December 2015
158. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
     Performance of magnetic resonance elastography in primary sclerosing cholangitis.
     J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
     PubMed     Text format     Abstract available
     
     
     November 2015
159. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
     The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
     J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
     PubMed     Text format     Abstract available
     
     
     
160. KIM Y, Lee EJ, Jang HK, Kim CH, et al
     Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
     J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
     PubMed     Text format     Abstract available
     
     
     October 2015
161. WANG D, Wang Q, Yin J, Dong R, et al
     Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
     J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: